Skip to content
[BLP]BuyLegalPeptides.com Browse Catalog
/ Lot documentation / Analytical reports / Laboratory research materials
[ Document trail ] Every published lot carries its documentation.

Research.
Documented.
Traceable.

Every released lot is paired with the laboratory that tested it, the method and the version used, the sample and report dates, and the measured result with its units.

/ 02 · The layers

Every layer
is a field

The object is the record. Each sheet holds one part of it: where the material came from, who handled it, which method was run, what the laboratory reported, and every revision since.

/ 03 · The record

Numbers,
not verdicts

A measurement is published with its method, its units and its date. Laboratory data is not turned into a guarantee, a conclusion or a pass mark.

[ Lot 4417-A ] · 99.2 % by HPLC-UV, 214 nm
/ 05 · Catalog

Research materials

Each listing carries the lot currently released against it, the method that produced the result, and the date it was reported. Open the record to read the report itself.

BPC-157, laboratory vial Single peptide

BPC-157

5 mg · CAS 137525-51-0
[ LOT 4417-A ] 99.2 % by HPLC-UV, 214 nm Janoshik Analytical · reported 2026-07-21
Add to order
TB-500, laboratory vial Single peptide

TB-500

5 mg · thymosin β4 fragment
[ LOT 4402-B ] 99.0 % by HPLC-UV, 214 nm Janoshik Analytical · reported 2026-07-11
Add to order
BPC-157 + TB-500, laboratory vial Blend

BPC-157 + TB-500

10 mg · two sequences
[ LOT 4390-A ] 98.8 % by HPLC-UV, 214 nm Colmaric Analyticals · reported 2026-06-28
Add to order
GHK-Cu, laboratory vial Single peptide

GHK-Cu

50 mg · copper tripeptide
[ LOT 4381-C ] 99.1 % by HPLC-UV, 214 nm Janoshik Analytical · reported 2026-06-19
Add to order
Ipamorelin, laboratory vial Single peptide

Ipamorelin

5 mg · CAS 170851-70-4
[ LOT 4377-A ] 99.4 % by HPLC-UV, 214 nm Janoshik Analytical · reported 2026-06-14
Add to order
CJC-1295 (no DAC), laboratory vial Single peptide

CJC-1295 (no DAC)

5 mg · CAS 863288-34-0
[ LOT 4369-D ] 99.0 % by HPLC-UV, 214 nm Colmaric Analyticals · reported 2026-06-05
Add to order
Semaglutide, laboratory vial GLP-1 research

Semaglutide

5 mg · lyophilised
[ LOT 4358-A ] 99.3 % by HPLC-UV, 214 nm Janoshik Analytical · reported 2026-05-30
$129.99 Open record →
Add to order
Tirzepatide, laboratory vial GLP-1 research

Tirzepatide

10 mg · lyophilised
[ LOT 4351-B ] 99.0 % by HPLC-UV, 214 nm Janoshik Analytical · reported 2026-05-22
$189.99 Open record →
Add to order
PT-141, laboratory vial Single peptide

PT-141

10 mg · bremelanotide
[ LOT 4344-C ] 98.9 % by HPLC-UV, 214 nm Colmaric Analyticals · reported 2026-05-14
Add to order
Selank, laboratory vial Cognitive

Selank

10 mg · CAS 129954-34-3
[ LOT 4336-A ] 99.0 % by HPLC-UV, 214 nm Janoshik Analytical · reported 2026-05-06
Add to order
Epithalon, laboratory vial Single peptide

Epithalon

50 mg · epitalon
[ LOT 4329-B ] 99.2 % by HPLC-UV, 214 nm Janoshik Analytical · reported 2026-04-28
Add to order
Bacteriostatic Water, laboratory vial Supplies

Bacteriostatic Water

30 ml · 0.9 % benzyl alcohol
[ LOT 4318-A ] USP monograph, supplier report Supplier documentation · reported 2026-04-16
Add to order

All materials supplied for in vitro laboratory research only · not for use in humans or animals

/ 06 · The full schema

What a lot
record contains

A product name tells you what was ordered. The lot tells you what was supplied. Each released lot is given its own identifier and its own permanent record, and the record is where the detail lives.

Documents stay attached to their lot. Corrections are dated. Superseded files stay reachable. Where a field is not yet part of the record, it is named below rather than left out.

Field Source
BLP lot Assigned at release
Source manufacturer lot Supplier documentation
Country of origin Supplier declaration
Date received, date sampled BLP receiving record
Sampled by Named, BLP
Chain-of-custody identifier Sample handling record
Laboratory, accreditation scope The testing laboratory
Method and method version The testing laboratory
Sample receipt and test dates The testing laboratory
Measured result, units, detection limit The analytical report
Original report, as issued Published file
Revision and correction history Public, dated
Commercial state, written in words BLP
File checksum Not in the record yet · scheduled
Raw analytical file Not in the record yet · scheduled
/ 07 · Lot records

Open the evidence

Do not take a product page on faith. Select a lot to read the laboratory, the method, the dates, the measured result and the documents held against it.

[ LOT 4417-A ] Record · rev 1
Catalog
BLP-1104-05
Form
5 MG · LYOPHILISED
Laboratory
Janoshik Analytical
Scope
ISO/IEC 17025 · HPLC-UV
Method
HPLC-07 · rev 3
Sampled
2026-07-14
Reported
2026-07-21
State
Available
Result
99.2 % by HPLC-UV, 214 nm

The result is the chromatographic purity of the sample submitted for this lot, by the stated method on the stated date. It describes that sample and no other, and it says nothing about behaviour in any system.

/ 08 · Testing

Methods, and what
they do not establish

A method answers one question about one submitted sample on one date. The column on the right is the part usually left off, and it is the part that tells you what a result is worth.

Method
What it measures
What it does not establish
HPLC-07 RP-HPLC-UV, 214 nm
Chromatographic purity of the submitted sample, reported as area percent against the stated gradient.
Identity, mass, water content, endotoxin, or how the material behaves in any system.
MS-02 ESI-MS
Observed monoisotopic mass of the submitted sample against the mass calculated for the stated sequence.
Purity, quantity, or the presence of related substances below the detection limit.
AA-03 Amino acid analysis
Residue ratios of the hydrolysed sample against the stated sequence.
Sequence order, purity, or the identity of any impurity.
KF-01 Karl Fischer titration
Water content of the submitted sample, percent by mass.
Purity, identity, or storage behaviour after the sample date.
BET-05 LAL, kinetic chromogenic
Endotoxin in EU per mg, for the lots submitted for it. Named as not run where it was not submitted.
Sterility, purity, identity, or anything about a lot that was not submitted for this test.
/ 09 · Documentation

How BLP writes
things down

Five rules the catalog, the packaging, the emails and the support replies are all held to.

01

The lot is the product

A product name tells you what was ordered. The lot tells you what was supplied. Every released lot gets its own identifier and its own document record.

02

Open the evidence

The laboratory, the method, the sample date, the measured result, the report and the document history are published on the lot page, not summarised into a sentence.

03

Numbers, not verdicts

A measurement is reported with its method, its units and its date. Laboratory data is not turned into a guarantee, a conclusion or a pass mark, and no result is printed without the method that produced it.

04

Records that survive scrutiny

Documents stay attached to their lot. Corrections are dated and the superseded file stays reachable. Where information is missing, the record says so instead of leaving the field out.

05

Access has a standard

Material is supplied for in vitro laboratory research. Product selection, pairing, fulfilment, support replies and documentation are held to that context without exception.

/ 10 · Access

Access has
a standard

BLP supplies material for in vitro laboratory research. Product selection, communication, fulfilment and documentation are all held to that context. Wholesale accounts are opened after the account details are checked against it.

[ Caution ]

For in vitro laboratory research only.
Not for use in humans or animals.
Not for clinical or diagnostic use.
Restrict access to trained laboratory personnel.

Bacteriostatic water, syringes, needles, dosing charts and reconstitution cards are not sold, bundled or shipped by BLP.